We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Development of a Highly Efficient CRISPR/Cas9-Mediated Herpesvirus of Turkey-Based Vaccine against Novel Variant Infectious Bursal Disease Virus.
- Authors
Zhang, Jun-Feng; Park, Jong-Yeol; Kim, Sang-Won; Choi, Yu-Ri; Cha, Se-Yeoun; Jang, Hyung-Kwan; Wei, Bai; Kang, Min
- Abstract
Infectious bursal disease (IBD), caused by IBD virus (IBDV), is an extremely contagious immunosuppressive disease that causes major losses for the poultry industry worldwide. Recently, the novel variant IBDV (G2d) has been highly prevalent in Korea, but the current vaccines against this very virulent IBDV have limited efficacy against this novel variant. To develop a vaccine against this variant IBDV, a recombinant virus designated rHVT-VP2 was constructed by inserting the IBDV (G2d) VP2 gene into herpesvirus of turkeys (HVT) using CRISPR/Cas9 gene-editing technology. The PCR and sequencing results obtained showed that the recombinant virus rHVT-VP2 was successfully constructed. Vaccination with rHVT-VP2 generated IBDV-specific antibodies in specific pathogen-free chickens starting from 2 weeks post-immunization. Seven days after the challenge, the autopsy results showed that the bursa atrophy rates of the rHVT-VP2, HVT, vaccine A, and positive control groups were 0%, 100%, 60%, and 100%, respectively, and the BBIX values were 1.07 ± 0.22, 0.27 ± 0.05, 0.64 ± 0.33, and 0.32 ± 0.06, respectively. These results indicate that rHVT-VP2 can provide 100% protection against a challenge with the IBDV (G2d), whereas vaccine A only provides partial protection. In conclusion, vaccination with the recombinant virus rHVT-VP2 can provide chickens with effective protection against variant IBDV (G2d).
- Subjects
TURKEY; SOUTH Korea; INFECTIOUS bursal disease virus; CRISPRS; CLASSICAL swine fever; RECOMBINANT viruses; COMMUNICABLE diseases; VACCINES
- Publication
Vaccines, 2024, Vol 12, Issue 3, p226
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines12030226